Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results